Hicure Pharmacare Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 15.67%
(FY 2023)
- Profit -35.06%
(FY 2023)
- Ebitda -7.22%
(FY 2023)
- Net Worth 79.95%
(FY 2023)
- Total Assets -23.12%
(FY 2023)
About Hicure Pharmacare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jemelaa Rajasekar and Inbaraj Griffth serve as directors at the Company.
- CIN/LLPIN
U85300TN2020PTC138325
- Company No.
138325
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Hicure Pharmacare Private Limited offer?
Hicure Pharmacare Private Limited offers a wide range of products and services, including Child and Baby Care Products, Baby Creams & Lotion, Physiotherapy & Rehab Aids, Rehabilitation Equipment, Baby Care Products, Hand Sanitizers & Personal Hygiene, Hair Shampoo, Baby Wipe, Common Disease Medicines, Antiseptic Mouthwashes.
Who are the key members and board of directors at Hicure Pharmacare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jemelaa Rajasekar  | Managing Director | 01-Oct-2020 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Inbaraj Griffth | Director | 01-Oct-2020 | Current |
Financial Performance of Hicure Pharmacare.
Hicure Pharmacare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.67% increase. The company also saw a substantial fall in profitability, with a 35.06% decrease in profit. The company's net worth Soared by an impressive increase of 79.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hicure Pharmacare?
Unlock access to Hicure Pharmacare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hicure Pharmacare?
Hicure Pharmacare has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hicure Pharmacare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hicure Pharmacare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
